pembrolizumab - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
KEYTRUDA pembrolizumab (rch) 50 mg powder for injection vial
AUST R: 226597
Active ingredients:
pembrolizumab

Dosage form:
Injection, powder for

Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd

Phone:
1800 818 553

Deletion from market:
01 Apr 2021

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Other